Biotech beauty brand Ourself has introduced a re-engineered version of its award-winning Replenishing Lip Filler. Powered by patented Tiered-Release Vesicle™ (TRV™) technology, the updated formula delivers dual-weight hyaluronic acid and peptides deep into the lips – restoring volume, smoothing texture, and enhancing definition.
“This launch strengthens our position in both the professional and consumer markets,” said Jim Hartman, CEO of Ourself. “We’re giving aesthetic clinicians a tool they can confidently recommend to complement injectable procedures, and consumers a way to achieve measurable volume without needles. It’s a win for both sides.”
According to a 2024 report, lip augmentation procedures have increased nearly 60% since 20001, reflecting rising demand for customizable lip solutions1. Replenishing Lip Filler offers a non-invasive option to enhance the appearance of lips that is backed by clinical data.
“This is a game changer,” said Dr. Carolyn Jacob, investigator on the study. “Achieving 0.61 cc in volume – more than half a syringe of HA – without a needle is remarkable. We saw measurable improvements in definition, contour, and overall lip aesthetics.”
Across two clinical studies, the treatment showed strong results:
- Over 99% of subjects reported improved overall lip appearance and volume2
- 94% showed increased shine2
- 94% showed improved vermilion border definition2
- Volume gains of 0.61 cc confirmed via 3D imaging3
The formula includes:
- HA+ Complex: Dual-weight HA + boosters + protectors
- Peptides: Support collagen and elastin
- Antioxidants: Visibly restore contour
- Benzyl Nicotinate: Boosts natural color
“Our goal was maximum impact with less complexity,” said Tina Fleck, VP of R&D. “This truly is as close as you can get to filler – without the needle.”
